5.1 Graviditet - SBU

maternal venous thromboembolic disease.
Thromb Haemost 1989;61:189-96.
78. Ginsberg JS, Hirsh J, Turner DC, et al.
Risks to the fetus of anticoagulant therapy
during pregnancy. Thromb Haemost 1989;
61:197-203.
79. Ginsberg JS, Kowalchuk G, Hirsh J,
et al. Heparin therapy during pregnancy.
Risks to the fetus and mother. Arch Intern
Med 1989;149:2233-6.
80. Ginsberg JS, Kowalchuk G, Hirsh J,
et al. Heparin effect on bone density.
Thromb Haemost 1990;64:286-9.
81. Ginsberg JS, Brill-Edwards P,
Burrows RF, et al. Venous thrombosis
during pregnancy: leg and trimester of
presentation. Thromb Haemost 1992;67:
519-20.
82. Ginsberg JS, Greer I, Hirsh J. Use of
antithrombotic agents during pregnancy.
Chest 2001;119:122S-31S.
83. Glueck CJ, Kupferminc MJ,
Fontaine RN, et al. Genetic hypofibrinolysis
in complicated pregnancies. Obstet
Gynecol 2001;97:44-8.
84. Goodrich SM, Wood JE. Peripheral
venous blood flow during pregnancy or
during oral contraceptive therapy. Am J
Obstet Gynecol 1964;90:740-44.
85. Grandone E, Margaglione M,
Colaizzo D, et al. Genetic susceptibility to
pregnancy-related venous thromboembolism:
roles of factor V Leiden, prothrombin
G20210A, and methylenetetrahydrofolate
reductase C677T mutations. Am J Obstet
Gynecol 1998;179:1324-8.
86. Grandone E, Margaglione M,
Colaizzo D, et al. Prothrombotic genetic
risk factors and the occurrence of
gestational hypertension with or without
proteinuria. Thromb Haemost 1999;81:
349-52.
87. Greer IA, Barry J, Mackon N, Allan PL.
Diagnosis of deep venous thrombosis in
pregnancy: a new role for diagnostic ultrasound.
Br J Obstet Gynaecol 1990;97:53-7.
88. Guillonneau M, de Crepy A,
Aufrant C, et al. [Breast-feeding is possible
in case of maternal treatment with
enoxaparin]. Arch Pediatr 1996;3:513-4.
89. Hahn CL. Pulsatile heparin administration
in pregnancy: a new approach. Am J
Obstet Gynecol 1986;155:283-7.
90. Harenberg J, Leber G, Zimmermann R,
Schmidt W. [Prevention of thromboembolism
with low-molecular weight heparin in
pregnancy]. Geburtshilfe Frauenheilkd
1987;47:15-8.
91. Harenberg J, Schneider D,
Heilmann L, Wolf H. Lack of anti-factor
Xa activity in umbilical cord vein samples
after subcutaneous administration of
heparin or low molecular mass heparin in
pregnant women. Haemostasis 1993;23:
314-20.
92. Haverkate F, Samama M. Familial
dysfibrinogenemia and thrombophilia.
Report on a study of the SSC Subcommittee
on Fibrinogen. Thromb Haemost
1995;73:151-61.
93. Heilmann L, Hojnacki B, Fischer WM.
[Deep venous thrombosis in pregnancy:
risk factors and possibilities for prevention].
Z Geburtshilfe Perinatol 1990;194:275-8.
KAPITEL 5.1 • GRAVIDITET 355